CVS Caremark, the largest PBM in the U.S., tells activists Gilead needs to lower the price of its new HIV drug to get on ...

Pricing issues have taken precedence as CVS Health’s (NYSE:CVS) pharmacy benefit manager, CVS Caremark, continues to hold off ...

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

Cigna Group said on Monday it will eliminate prescription drug rebates in many of its commercial health plans in 2027, and offer up-front discounts at its pharmacy counters to lower costs for patients ...

DeVaney will lead CVS’ pharmacy benefit manager after roughly two months in the interim role, the healthcare giant said in a Monday press release. Before serving as interim president at Caremark, ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CVS Caremark, the pharmaceutical subsidiary of CVS Health, announced Wednesday it will replace AbbVie’s Humira from its list of covered drugs with cheaper alternatives for some customers—a move that’s ...

A federal judge has ordered CVS Health’s pharmacy benefit manager, Caremark, to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more ...

A federal judge has ordered CVS Health’s pharmacy benefit manager, Caremark, to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more ...

Shareholders of Caremark Rx yesterday voted to accept a $27 billion acquisition offer from CVS, a deal that would create a prescription drugs distribution giant. The approval ended a drawn-out bidding ...

Cigna Group said on Monday it will eliminate prescription drug rebates in many of its commercial health plans in 2027. The move aims to lower costs for patients at the pharmacy counter with up-front ...